Former Acting Chief Financial Officer · Elanco Animal Health Inc (ELAN)

Lucas Montarce

A named executive officer of Elanco Animal Health in every fiscal year CompBrief holds from FY2017 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$1,354,228

Salary $335,175Stock awards $616,019Bonus $200,000

FY2017: $518,245

6th of 7 named executive officers at Elanco Animal Health by FY2018 total.

7 named officers on file for Elanco Animal Health, FY2018

Lucas Montarce’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing
  • ELAN’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Elanco Animal Health’s whole pay program stands against its peers

  • Elanco Animal Health’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ELAN→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 3, 2019 (DEF 14A).

Free

Get Lucas Montarce’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Lucas Montarce compensation by year

Elanco Animal Health Summary Compensation Table · all 2 fiscal years held
In US dollars, as Elanco Animal Health reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018
Salary$280,673$335,175
Bonus$0$200,000
Stock awards$112,500$616,019
Option awards$0$0
Non-equity incentive$83,976$138,404
Pension and deferred compensation$24,896$5,567
All other$16,200$20,111
Total$518,245$1,354,228

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Elanco Animal Health Inc DEF 14A filed April 3, 2019, accession 0001140361-19-006419, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Elanco Animal Health Inc filed document, accession 0001140361-19-006419. Every figure is read from that document and cited to the page and table it appears in. Filed April 3, 2019.

$518K
$1.4M
FY17
FY18
SalaryBonusNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
RSU4,395$508,589—
RSU3,162$365,907—
RSU3,141$363,477—
RSU1,014$117,340—

Per the Outstanding Equity Awards at Fiscal Year-End table in Elanco Animal Health Inc's FY2018 proxy; value at the fiscal year-end close, as the company printed it.

Elanco Animal Health’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Jeffrey SimmonsPresident and Chief Executive Officer$5,379,245
Sarena LinFormer Executive Vice President, Transformation and Technology$2,858,860
Christopher JensenFormer Chief Financial Officer$2,095,597
David UrbanekExecutive Vice President, Manufacturing and Quality$1,881,328
David KinardExecutive Vice President, Human Resources$1,652,499
Lucas Montarce · this pageFormer Acting Chief Financial Officer$1,354,228
Todd YoungExecutive Vice President and Chief Financial Officer$680,653

The full Elanco Animal Health compensation record

free company brief

This page is one person within Elanco Animal Health's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Elanco Animal Health proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Elanco Animal Health's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Lucas Montarce's compensation dossier · One-time report. No refunds.